Abstract
Sadia Zafar, Megin E. Nguyen, Ramaiah Muthyala, Yuk Yin Sham
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
10.1074/jbc.m210525200
10.1074/jbc.m210525200
The postsynaptic organization of synapses
10.1101/cshperspect.a005678 · 2011
Unresolved referenced work
2008
Structure, function, and plasticity of GABA transporters
10.3389/fncel.2014.00161 · 2014
Synaptic GABA release prevents GABA transporter type-1 reversal during excessive network activity
10.1038/ncomms7597 · 2015
Trafficking of the plasma membrane γ-Aminobutyric acid transporter GAT1 size and rates of an acutely recycling pool
10.1074/jbc.m500381200 · 2005
The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice
10.1016/j.pharep.2015.04.018 · 2015
10.1016/j.neuropharm.2011.01.022
10.1016/j.neuropharm.2011.01.022
GABAergic dysfunction in Schizophrenia : New treatment strategies on the horizon
10.1016/j.schres.2010.02.164 · 2010
10.1529/biophysj.105.061002
10.1529/biophysj.105.061002
Role of the conserved glutamine 291 in the rat γ-aminobutyric acid transporter rGAT-1
10.1007/s00018-005-5512-6 · 2006
Unresolved referenced work
2013
Selective GABA transporter inhibitors tiagabine and EF1502 exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABAA receptor agonist gaboxadol
10.1124/jpet.111.179671 · 2011
10.1023/a:1022393604014
10.1023/a:1022393604014
On the bioactive conformation of the GABA uptake inhibitor SK&F 89976-a
10.1016/s0960-894x(96)00268-5 · 1996
GABA transporters (GAT-1) in Alzheimer's disease
10.1007/s007020050230 · 1999
GABA uptake inhibitors. Synthesis and effects on audiogenic seizures of ester prodrugs of nipecotic acid, guvacine and cis-4-hydroxynipecotic acid
1987
10.1002/cmdc.201000100
10.1002/cmdc.201000100
10.1038/nsmb.1854
10.1038/nsmb.1854
10.1126/science.1166777
10.1126/science.1166777
10.1007/s00232-015-9797-6
10.1007/s00232-015-9797-6
10.1523/jneurosci.16-17-05405.1996
10.1523/jneurosci.16-17-05405.1996
10.1073/pnas.0705600104
10.1073/pnas.0705600104
10.1074/jbc.m801093200
10.1074/jbc.m801093200
10.1038/nature14431
10.1038/nature14431
10.1111/j.1471-4159.2009.05982.x
10.1111/j.1471-4159.2009.05982.x
10.1074/jbc.m110.149732
10.1074/jbc.m110.149732
10.1038/nature03978
10.1038/nature03978
A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function
10.1124/mol.106.026120 · 2006
10.1021/ja9621760
10.1021/ja9621760
10.1016/s0022-2836(95)80037-9
10.1016/s0022-2836(95)80037-9
10.1002/prot.10286
10.1002/prot.10286
10.1002/pro.5560020916
10.1002/pro.5560020916
10.1021/jm051256o
10.1021/jm051256o
10.1021/jm030644s
10.1021/jm030644s
10.1021/jm0306430
10.1021/jm0306430
Hippocampal GABA transporter function in temporal-lobe epilepsy
10.1038/376174a0 · 1995
10.1016/j.neuron.2007.10.021
10.1016/j.neuron.2007.10.021
10.1002/cbic.200400207
10.1002/cbic.200400207
Seizures in a pediatric patient with a tiagabine overdose
10.1007/bf03161185 · 2006
Neurotransmitter transporters: molecular function of important drug targets
10.1016/j.tips.2006.05.003 · doi-reference
10.1021/jm5015428
10.1021/jm5015428 · doi-reference
Major human γ-aminobutyrate transporter: in silico prediction of substrate efficacy
10.1016/j.bbrc.2007.10.108 · doi-reference
A Na+/Cl−-coupled GABA Transporter, GAT-1, from Caenorhabditis elegans structural and functional features, specific expression in GABA-ergic neurons, and involvement in muscle function
10.1074/jbc.m408470200 · doi-reference
Inhibitory action of antidepressants on mouse Betaine/GABA transporter (BGT1) heterologously expressed in cell cultures
10.3390/ijms13032578 · doi-reference
Structure, function, and modulation of γ-aminobutyric acid transporter 1 (GAT1) in neurological disorders: a pharmacoinformatic prospective
10.3389/fchem.2018.00397 · doi-reference